Pfizer Inc. (NYSE:PFE) announced today that a total of 10 abstracts on . . .
You are here
Press Release Archive
Pfizer Inc. (NYSE:PFE) today announced full results from the Phase 2 clinical trial of the investigational, next-generation tyrosine kinase inhibitor . . .
This Metastatic Breast Cancer Awareness Day, the Union for International Cancer Control (UICC) and Pfizer Oncology are proud . . .
Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved . . .
Pfizer Inc. today announced that it is reviewing strategic alternatives for its Consumer Healthcare business. A range of options will be considered . . .
Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together . . .
Leading health care organizations AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are joining Walgreens...
The board of directors of Pfizer Inc. today declared a 32-cent fourth-quarter 2017 dividend on the company’s . . .
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved...
Like many Baby Boomers, award-winning entertainer and music icon Patti LaBelle takes steps to stay healthy . . .
Pfizer Inc. (NYSE:PFE), the National Newspaper Publishers Association (NNPA), and scholars from Howard University today announced results ...
New research released today by The Economist Intelligence Unit (EIU), a division of The Economist...
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for BAVENCIO® (avelumab) as a monotherapy for the treatment of . . .
To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer today filed suit in the U.S. District Court for the Eastern District of Pennsylvania against Johnson & Johnson (J&J).
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted 6 in favor and 6 against the benefit-risk . . .
Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced today that the Phase 3 PROSPER . . .
Pfizer today announced final overall...
Pfizer today announced...
Pfizer invites investors and the general public...
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration approved MYLOTARG™ (gemtuzumab ozogamicin) . . .
Note: These press releases were issued in the United States and are intended as reference information for U.S. investors and journalists. The information contained in each press release was accurate at the time of issuance, and Pfizer assumes no responsibility for updating the information to reflect subsequent developments.
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.